LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr | ₹5.07 Cr |
What is the latest Total Debt ratio of LINCOLN PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹1.07 Cr |
Mar2023 | ₹2.00 Cr |
Mar2022 | ₹2.04 Cr |
Mar2021 | ₹0.52 Cr |
Mar2020 | ₹5.07 Cr |
How is Total Debt of LINCOLN PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹1.07 Cr | -46.57 | |
Mar2023 | ₹2.00 Cr | -2.30 | |
Mar2022 | ₹2.04 Cr | 293.08 | |
Mar2021 | ₹0.52 Cr | -89.75 | |
Mar2020 | ₹5.07 Cr | - |
Compare Total Debt of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,125.4 Cr | 2% | 3.9% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | 2% |
3.9% |
-5.9% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses